As reported on PM Live, a new clinical trial hub focused on epidermolysis bullosa (EB) has been established at University Medical Center Groningen (UMCG) in
To the patient, the parent, the caregiver, and the person in the “limbo” of waiting: I am one of you. My name is Aaron Jackson,
Triple-Target Immunotherapy for Solid Tumors Advances - Novel Antibody Enters Pivotal Testing Phase bit.ly/3OPyK9q Read now at PatientWorthy.com
#PatientWorthy #TumorTreatment #cancer Treatment
Today, we had the pleasure of meeting the RareArtist awardees at Rare Disease Week in DC. The Rare Artist Gallery offers attendees the opportunity to connect with and view artwork created by the 2025 Rare Artist Awardees. Stay tuned for a few amazing story shares from @daice_d_marshall living with Granulomatosis with Polyangiitis (GPA); @evaagus.art living with nasopharyngeal carcinoma; Beatriz living with neurosarcoidosis; Krista living with Ushers Syndrome; and Zanny who is living with CRPS.
#PatientWorthy #raredc2026
Patient Worthy is looking for individuals who are interested in sharing their experiences with Myositis. Be the reason someone feels seen, supported, and inspired! If you're interested in learning more or joining the conversation this week, visit patientworthy.com for the latest information. If you have a story to share, click here: bit.ly/4dV7gru
#myositis #shareyourstory #PatientWorthy
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
